New Potomac Partners LLC Reduces Holdings in Walgreens Boots Alliance Inc (NASDAQ:WBA)

New Potomac Partners LLC lessened its position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 47.2% during the second quarter, Holdings Channel reports. The institutional investor owned 13,514 shares of the pharmacy operator’s stock after selling 12,065 shares during the quarter. New Potomac Partners LLC’s holdings in Walgreens Boots Alliance were worth $739,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently modified their holdings of WBA. Roman Butler Fullerton & Co. lifted its holdings in Walgreens Boots Alliance by 28.8% during the 1st quarter. Roman Butler Fullerton & Co. now owns 22,127 shares of the pharmacy operator’s stock worth $1,400,000 after purchasing an additional 4,942 shares in the last quarter. Newman Dignan & Sheerar Inc. lifted its holdings in Walgreens Boots Alliance by 22.9% during the 1st quarter. Newman Dignan & Sheerar Inc. now owns 4,616 shares of the pharmacy operator’s stock worth $292,000 after purchasing an additional 861 shares in the last quarter. Truvestments Capital LLC purchased a new stake in Walgreens Boots Alliance during the 1st quarter worth about $312,000. Cornerstone Advisors Inc. lifted its holdings in Walgreens Boots Alliance by 131.6% during the 2nd quarter. Cornerstone Advisors Inc. now owns 894 shares of the pharmacy operator’s stock worth $49,000 after purchasing an additional 508 shares in the last quarter. Finally, Trust Investment Advisors lifted its holdings in Walgreens Boots Alliance by 4.5% during the 1st quarter. Trust Investment Advisors now owns 9,260 shares of the pharmacy operator’s stock worth $586,000 after purchasing an additional 400 shares in the last quarter. 62.12% of the stock is currently owned by hedge funds and other institutional investors.

NASDAQ WBA traded down $0.64 during trading on Tuesday, reaching $51.23. The company’s stock had a trading volume of 371,728 shares, compared to its average volume of 4,256,189. The company has a market capitalization of $47.16 billion, a PE ratio of 8.49, a PEG ratio of 1.34 and a beta of 0.81. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.76 and a quick ratio of 0.37. The stock has a fifty day moving average of $54.40. Walgreens Boots Alliance Inc has a one year low of $49.31 and a one year high of $86.31.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Thursday, June 27th. The pharmacy operator reported $1.47 EPS for the quarter, beating the consensus estimate of $1.42 by $0.05. The firm had revenue of $34.59 billion for the quarter, compared to analyst estimates of $34.52 billion. Walgreens Boots Alliance had a return on equity of 22.08% and a net margin of 3.53%. The company’s revenue was up .7% on a year-over-year basis. During the same period in the prior year, the company earned $1.53 EPS. As a group, equities analysts forecast that Walgreens Boots Alliance Inc will post 5.99 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 12th. Stockholders of record on Tuesday, August 20th will be given a dividend of $0.458 per share. The ex-dividend date is Monday, August 19th. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.44. This represents a $1.83 annualized dividend and a dividend yield of 3.58%. Walgreens Boots Alliance’s dividend payout ratio is 29.24%.

A number of equities analysts have weighed in on the company. Morgan Stanley set a $61.00 target price on Walgreens Boots Alliance and gave the stock a “hold” rating in a research note on Tuesday, May 14th. Zacks Investment Research lowered Walgreens Boots Alliance from a “hold” rating to a “sell” rating and set a $53.00 target price on the stock. in a research note on Monday, June 10th. JPMorgan Chase & Co. decreased their target price on Walgreens Boots Alliance from $74.00 to $73.00 and set an “overweight” rating on the stock in a research note on Friday, June 28th. BidaskClub lowered Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a research note on Monday, June 24th. Finally, ValuEngine upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Friday, June 28th. Six equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and four have given a buy rating to the company’s stock. Walgreens Boots Alliance currently has a consensus rating of “Hold” and an average target price of $63.82.

In other news, CAO Marco Patrick Anthony Pagni sold 20,000 shares of the stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $53.05, for a total transaction of $1,061,000.00. Following the transaction, the chief accounting officer now directly owns 435,811 shares in the company, valued at approximately $23,119,773.55. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 15.73% of the stock is currently owned by corporate insiders.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Featured Article: Gap Up Stocks

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.